CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled / 24 target
Drug / intervention
Facial mask (V2 Mask™, Hans Rudolph) +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07631481
NCT07631481N/ACompletedOn Track (0.9/mo)Completion was 22mo ago

Body Posture and Interface Effects on Peak Cough Flow in Healthy Adults: A Randomized Crossover Study

Cliniques universitaires Saint-Luc- Université Catholique de Louvain·interventional·Posted Jun 8, 2026·Updated Jun 8, 2026

In Brief

A clinical study evaluating Facial mask (V2 Mask™, Hans Rudolph) and Mouthpiece (Pulmosafe, Lemon Medical) with nose clip for Peak Cough Flow Measurement. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Cough is a key airway protective mechanism requiring coordinated neuromuscular function. Peak cough flow (PCF) is a simple, non-invasive measure widely used to assess cough effectiveness and guide clinical decisions. Current ATS/ERS guidelines recommend measuring PCF in a seated position using a mouthpiece with a nose clip; however, this setup is not always feasible in clinical practice. Some patients cannot maintain posture or ensure an adequate mouthpiece seal, making a facial mask a potential alternative. The influence of body position and interface on PCF measurements remains unclear, with limited evidence from randomized crossover studies. This study aims to evaluate the effects of body position (sitting vs standing) and measurement interface (mouthpiece vs facial mask) on PCF in healthy young adults. In a randomized within-subject crossover design, participants perform PCF measurements under four conditions (Sit-Mask, Stand-Mask, Sit-Mouthpiece, Stand-Mouthpiece) during a single session. The findings will help inform more flexible and standardized PCF assessment procedures in clinical practice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedJun 8, 2026
Enrollment StartMay 1, 2024
Primary CompletionAug 31, 2024
Study CompletionMay 21, 2026
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 24 days ago

Arms & Interventions

Sit-Maskactive_comparator

Device: Facial mask (V2 Mask™, Hans Rudolph)
Stand-Maskactive_comparator

Device: Facial mask (V2 Mask™, Hans Rudolph)
Sit-Mouthpieceactive_comparator

Device: Mouthpiece (Pulmosafe, Lemon Medical) with nose clip
Stand-Mouthpieceactive_comparator

Device: Mouthpiece (Pulmosafe, Lemon Medical) with nose clip

Interventions

Facial mask (V2 Mask™, Hans Rudolph)device

Peak cough flow measured in the seated position. The facial mask (V2 Mask™, Hans Rudolph, Inc., Kansas, USA; size fitted to participant) was connected to an ultrasonic spirometer (SpiroScout, Ganshorn) via a PFT filter. Participants performed three tidal breaths followed by a maximal cough, repeated three times.

Facial mask (V2 Mask™, Hans Rudolph)device

Peak cough flow measured in the standing position. Same device and procedure as Sit-Mask condition.

Mouthpiece (Pulmosafe, Lemon Medical) with nose clipdevice

Peak cough flow measured in the seated position. The mouthpiece (Pulmosafe, Lemon Medical GmbH, Hammelburg, Germany) was used with a nose clip and connected to an ultrasonic spirometer (SpiroScout, Ganshorn) via a PFT filter. Participants performed three tidal breaths followed by a maximal cough, repeated three times.

Mouthpiece (Pulmosafe, Lemon Medical) with nose clipdevice

Peak cough flow measured in the standing position. Same device and procedure as Sit-Mouthpiece condition.